Economic burden of multiple sclerosis: a cross-sectional study in Iran

BACKGROUND: Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex and ReciGen) and second (Fingolimod and Natalizumab) drug therapy lines. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaee, Mehdi, Keshavarz, Khosro, Izadi, Sadegh, Jafari, Abdosaleh, Ravangard, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725304/
https://www.ncbi.nlm.nih.gov/pubmed/34981265
http://dx.doi.org/10.1186/s13561-021-00350-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725304/
https://www.ncbi.nlm.nih.gov/pubmed/34981265
http://dx.doi.org/10.1186/s13561-021-00350-y

Ejemplares similares